A total of 151 institutions have reported a stake in Zevra Therapeutics, Inc. (NASDAQ:ZVRA) as of December 2025, according to recent 13F filings with the SEC.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 4,507,051 | 469,897 | 11.64% | $40,383,177.00 |
| Woodline Partners LP | 31 Dec, 2025 | 3,450,844 | -25,299 | -0.73% | $30,919,562.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 3,305,207 | 221,845 | 7.19% | $29,614,655.00 |
| Caption Management, LLC | 31 Dec, 2025 | 2,841,712 | 182,721 | 6.87% | $25,461,740.00 |
| FMR LLC | 31 Dec, 2025 | 2,393,493 | 758,922 | 46.43% | $21,445,699.00 |
| Nantahala Capital Management, LLC | 31 Dec, 2025 | 1,771,936 | -200,000 | -10.14% | $15,876,546.00 |
| STATE STREET CORP | 31 Dec, 2025 | 1,482,956 | 55,665 | 3.90% | $13,287,286.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 1,341,681 | 41,341 | 3.18% | $12,024,511.00 |
| MORGAN STANLEY | 31 Dec, 2025 | 1,157,913 | 601,963 | 108.28% | $10,374,901.00 |
| MILLENNIUM MANAGEMENT LLC | 31 Dec, 2025 | 1,134,358 | 99,107 | 9.57% | $10,163,848.00 |
| Legal & General Group Plc | 31 Dec, 2025 | 1,097,988 | 44,589 | 4.23% | $9,837,973.00 |
| 683 Capital Management, LLC | 31 Dec, 2025 | 905,000 | -70,000 | -7.18% | $8,108,800.00 |
| ROYCE & ASSOCIATES LP | 31 Dec, 2025 | 865,822 | 174,583 | 25.26% | $7,757,765.00 |
| D. E. Shaw & Co., Inc. | 31 Dec, 2025 | 863,746 | 137,916 | 19.00% | $7,739,164.00 |
| CITADEL ADVISORS LLC | 31 Dec, 2025 | 842,854 | 651,058 | 339.45% | $7,551,972.00 |
| TUDOR INVESTMENT CORP ET AL | 31 Dec, 2025 | 692,097 | 244,201 | 54.52% | $6,201,189.00 |
| MARSHALL WACE, LLP | 31 Dec, 2025 | 669,742 | -242,557 | -26.59% | $6,000,889.00 |
| Retirement Planning Co of New England, Inc. | 31 Dec, 2025 | 662,976 | 62,206 | 10.35% | $5,940,265.00 |
| JANE STREET GROUP, LLC | 31 Dec, 2025 | 634,906 | 352,904 | 125.14% | $5,688,758.00 |
| GOLDMAN SACHS GROUP INC | 31 Dec, 2025 | 612,300 | -149,477 | -19.62% | $5,486,208.00 |